ramosetron has been researched along with Colicky Pain in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, F; Li, Y; Qi, Q; Zhang, Y; Zuo, X | 1 |
Akiho, H; Fukudo, S; Haruma, K; Hayase, H; Hongo, M; Ida, M; Matsueda, K; Nakashima, Y | 1 |
Funatsu, T; Hirata, T; Keto, Y; Nakata, M; Sasamata, M | 1 |
Ito, H; Iwaoka, K; Kamato, T; Kiso, T; Miyata, K; Naitoh, Y; Yamaguchi, T | 1 |
2 review(s) available for ramosetron and Colicky Pain
Article | Year |
---|---|
Ramosetron for the treatment of irritable bowel syndrome with diarrhea: a systematic review and meta-analysis of randomized controlled trials.
Topics: Abdominal Pain; Benzimidazoles; Constipation; Diarrhea; Humans; Irritable Bowel Syndrome; Serotonin 5-HT3 Receptor Antagonists | 2018 |
Pharmacological profile of ramosetron, a novel therapeutic agent for IBS.
Topics: Abdominal Pain; Animals; Benzimidazoles; Defecation; Diarrhea; Dogs; Gastrointestinal Transit; Humans; Irritable Bowel Syndrome; Mice; Models, Animal; Rats; Serotonin Antagonists | 2007 |
1 trial(s) available for ramosetron and Colicky Pain
Article | Year |
---|---|
Optimal dose of ramosetron in female patients with irritable bowel syndrome with diarrhea: A randomized, placebo-controlled phase II study.
Topics: Abdominal Pain; Adult; Benzimidazoles; Diarrhea; Double-Blind Method; Female; Humans; Irritable Bowel Syndrome; Middle Aged; Serotonin Antagonists; Treatment Outcome | 2017 |
1 other study(ies) available for ramosetron and Colicky Pain
Article | Year |
---|---|
A novel 5-HT3 receptor agonist, YM-31636, increases gastrointestinal motility without increasing abdominal pain.
Topics: Abdominal Pain; Animals; Benzimidazoles; Colon; Defecation; Gastrointestinal Motility; Intestinal Mucosa; Male; Pressure; Pyrroles; Rats; Rats, Wistar; Reflex, Abdominal; Serotonin Antagonists; Serotonin Receptor Agonists; Thiazoles; Water | 2001 |